New research reveals marijuana users face 29% higher heart attack risk and doubled cardiovascular death chances, plus brain ...

Researchers found that people who began using cannabis regularly before the age of 15 were more likely, as young adults, to seek treatment for depression, anxiety, suicidal thoughts, and physical ...

Anxiety is now the most common qualifying condition for medical marijuana in Pennsylvania, surpassing chronic pain. The number of medical marijuana certifications issued monthly in Pennsylvania nearly ...

Is marijuana getting too high on its own promises? New research published Monday adds to the evidence that medical cannabis ...

Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived ...

Cannabis has become legalized and widespread across the country. With no federal regulation of local dispensaries, it is up to states to figure out how to manage the use of this substance. So, is ...

Patients with fibromyalgia who used cannabis-based medicinal products demonstrated modest, medium-term improvements in pain, anxiety and sleep, according to data published in Clinical Rheumatology.“It ...

Johns Hopkins University School of Medicine researchers studied the association between consumption of tetrahydrocannabinol-dominant cannabis products and anxiety and depression. The findings ...

Pennsylvania's medical marijuana program expanded rapidly in the years after clinical anxiety was added as a qualifying condition, University of Pittsburgh researchers found in a new study that traces ...

Faced with chronic nerve pain, many people turn to cannabis-based medications, hoping for relief that conventional treatments ...